New applications of gemcitabine and future directions in the management of pancreatic cancer
- 19 July 2002
- Vol. 95 (S4) , 941-945
- https://doi.org/10.1002/cncr.10753
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancerCancer, 2002
- Gemcitabine: Progress in the Treatment of Pancreatic CancerOncology, 2000
- Molecular Regulation of Constitutive Expression of Interleukin-8 in Human Pancreatic AdenocarcinomaJournal of Interferon & Cytokine Research, 2000
- Cooperation Between Transcription Factor AP-1 and NF-kappa B in the Induction of Interleukin-8 in Human Pancreatic Adenocarcinoma Cells by HypoxiaJournal of Interferon & Cytokine Research, 1999
- Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelAOncogene, 1999
- Phase I Trial of Twice-Weekly Gemcitabine and Concurrent Radiation in Patients With Advanced Pancreatic CancerJournal of Clinical Oncology, 1999
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997